Primary sclerosing cholangitis is a rare liver complication that can develop among people with inflammatory bowel disease. Early diagnosis can help, but there’s no cure.

Primary sclerosing cholangitis is a rare, unpreventable liver complication that can happen among people with inflammatory bowel disease.

Primary sclerosing cholangitis (PSC) affects the liver and bile ducts. Symptoms and treatment vary from person to person. PSC is a rare liver disease that affects the bile ducts. It’s progressive, ...

The global prevalence of primary biliary cholangitis has reached 18.1 cases per 100,000 people. The global prevalence of primary biliary cholangitis (PBC) has increased, particularly in the Western ...

Department of Pancreatic Surgery, The First Affiliated Hospital of Xinjiang Medical University, Ürümqi, China Background: Acute cholangitis, characterized by infection of the bile duct, represents a ...

Cholangitis and cholecystitis are two conditions that share some similarities but have different causes and symptoms. Cholangitis affects the bile ducts, while cholecystitis affects the gallbladder.

Your doctor may recommend a combination of medications, dietary supplements, and lifestyle changes to help manage primary biliary cholangitis (PBC). Some people eventually need a liver transplant to ...

Cholangitis describes inflammation in the bile ducts or biliary system. Some forms of cholangitis can be life threatening. Treatment may involve antibiotics, drainage of the bile duct, and intravenous ...

Correspondence to Dr Johannes R Hov, Norwegian PSC Research Center, Division of Surgery and Specialized Medicine, Oslo University Hospital, Oslo, Norway; j.e.r.hov{at}medisin.uio.no The puzzling ...

Individuals with primary biliary cholangitis and diabetes may experience worse outcomes, such as progression to end-stage liver disease. Among patients with primary biliary cholangitis (PBC), diabetes ...

The following is a summary of “Clinical characteristics of adrenal crisis in 371 adult patients with glucocorticoid-induced adrenal insufficiency,” published in the December 2024 issue of ...